Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Adamis Pharmaceuticals Corporation stock | $1.09

Learn how to easily invest in Adamis Pharmaceuticals Corporation stock.

Adamis Pharmaceuticals Corporation is a drug manufacturers-specialty & generic business based in the US. Adamis Pharmaceuticals Corporation shares (ADMP) are listed on the NASDAQ and all prices are listed in US Dollars. Adamis Pharmaceuticals Corporation employs 116 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Adamis Pharmaceuticals Corporation

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ADMP – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Adamis Pharmaceuticals Corporation stock price (NASDAQ: ADMP)

Use our graph to track the performance of ADMP stocks over time.

Adamis Pharmaceuticals Corporation shares at a glance

Information last updated 2021-10-18.
Latest market close$1.09
52-week range$0.39 - $1.80
50-day moving average $1.06
200-day moving average $0.97
Wall St. target price$1.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.64

Buy Adamis Pharmaceuticals Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Adamis Pharmaceuticals Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Adamis Pharmaceuticals Corporation price performance over time

Historical closes compared with the close of $1.09 from 2021-10-22

1 week (2021-10-13) N/A
1 month (2021-09-20) 5.83%
3 months (2021-07-23) 6.86%
6 months (2021-04-23) 45.33%
1 year (2020-10-23) 37.38%
2 years (2019-10-23) 51.39%
3 years (2018-10-23) 2.97
5 years (2016-10-21) 2.8

Adamis Pharmaceuticals Corporation financials

Revenue TTM $16.5 million
Gross profit TTM $1.6 million
Return on assets TTM -59.12%
Return on equity TTM -270.65%
Profit margin -298.84%
Book value $0.04
Market capitalisation $168.2 million

TTM: trailing 12 months

Shorting Adamis Pharmaceuticals Corporation shares

There are currently 9.6 million Adamis Pharmaceuticals Corporation shares held short by investors – that's known as Adamis Pharmaceuticals Corporation's "short interest". This figure is 0.9% down from 9.7 million last month.

There are a few different ways that this level of interest in shorting Adamis Pharmaceuticals Corporation shares can be evaluated.

Adamis Pharmaceuticals Corporation's "short interest ratio" (SIR)

Adamis Pharmaceuticals Corporation's "short interest ratio" (SIR) is the quantity of Adamis Pharmaceuticals Corporation shares currently shorted divided by the average quantity of Adamis Pharmaceuticals Corporation shares traded daily (recently around 1.8 million). Adamis Pharmaceuticals Corporation's SIR currently stands at 5.41. In other words for every 100,000 Adamis Pharmaceuticals Corporation shares traded daily on the market, roughly 5410 shares are currently held short.

However Adamis Pharmaceuticals Corporation's short interest can also be evaluated against the total number of Adamis Pharmaceuticals Corporation shares, or, against the total number of tradable Adamis Pharmaceuticals Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Adamis Pharmaceuticals Corporation's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Adamis Pharmaceuticals Corporation shares in existence, roughly 60 shares are currently held short) or 0.0648% of the tradable shares (for every 100,000 tradable Adamis Pharmaceuticals Corporation shares, roughly 65 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Adamis Pharmaceuticals Corporation.

Find out more about how you can short Adamis Pharmaceuticals Corporation stock.

Adamis Pharmaceuticals Corporation share dividends

We're not expecting Adamis Pharmaceuticals Corporation to pay a dividend over the next 12 months.

Have Adamis Pharmaceuticals Corporation's shares ever split?

Adamis Pharmaceuticals Corporation's shares were split on a 1:17 basis on 12 December 2013. So if you had owned 17 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Adamis Pharmaceuticals Corporation shares – just the quantity. However, indirectly, the new 1600% higher share price could have impacted the market appetite for Adamis Pharmaceuticals Corporation shares which in turn could have impacted Adamis Pharmaceuticals Corporation's share price.

Adamis Pharmaceuticals Corporation share price volatility

Over the last 12 months, Adamis Pharmaceuticals Corporation's shares have ranged in value from as little as $0.387 up to $1.8. A popular way to gauge a stock's volatility is its "beta".

ADMP.US volatility(beta: 1.35)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Adamis Pharmaceuticals Corporation's is 1.3497. This would suggest that Adamis Pharmaceuticals Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Adamis Pharmaceuticals Corporation overview

Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy and respiratory disease in the United States. The company's product candidates comprise Symjepi Injection pre-filled syringe (PFS) for use in the emergency treatment of acute allergic reactions, including anaphylaxis; dry powder inhaler products consisting of fluticasone for the treatment of asthma; beclomethasone, a metered dose inhaler product for the asthma; and naloxone injection product candidates for the treatment of opioid overdose. It also offers APC400, a tempol gel use of reducing radiation dermatitis in patients undergoing treatment for cancer; and APC410 for the treatment of respiratory diseases, including asthma, respiratory syncytial virus, influenza, and COVID-19. In addition, the company provides corticosteroids, hormone replacement therapies, hospital outsourcing products, injectables, urological preparations, topical compounds for pain, and men's and women's health products; and veterinary pharmaceutical products for animals. Adamis Pharmaceuticals Corporation was founded in 2006 and is headquartered in San Diego, California. .

Frequently asked questions

What percentage of Adamis Pharmaceuticals Corporation is owned by insiders or institutions?
Currently 1.064% of Adamis Pharmaceuticals Corporation shares are held by insiders and 10.813% by institutions.
How many people work for Adamis Pharmaceuticals Corporation?
Latest data suggests 116 work at Adamis Pharmaceuticals Corporation.
When does the fiscal year end for Adamis Pharmaceuticals Corporation?
Adamis Pharmaceuticals Corporation's fiscal year ends in December.
Where is Adamis Pharmaceuticals Corporation based?
Adamis Pharmaceuticals Corporation's address is: 11682 El Camino Real, San Diego, CA, United States, 92130
What is Adamis Pharmaceuticals Corporation's ISIN number?
Adamis Pharmaceuticals Corporation's international securities identification number is: US00547W2089
What is Adamis Pharmaceuticals Corporation's CUSIP number?
Adamis Pharmaceuticals Corporation's Committee on Uniform Securities Identification Procedures number is: 00547W109

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site